| 29/11/23 | 07:00:17 | 29 Nov 2023 | | ISO 27001 Information Security Certification |
| 20/11/23 | 07:00:06 | 20 Nov 2023 | | Investor Presentation |
| 15/11/23 | 07:00:11 | 15 Nov 2023 | | Commercialisation agreement with Thermo Fisher |
| 02/11/23 | 07:00:13 | 2 Nov 2023 | | Clarava™ poster to be presented at ASN Kidney Week |
| 29/09/23 | 07:00:14 | 29 Sept 2023 | | Half-year Report |
| 20/07/23 | 07:00:10 | 20 Jul 2023 | | CLIA Certificate of Compliance update |
| 06/07/23 | 07:00:08 | 6 Jul 2023 | | Investor Presentation |
| 03/07/23 | 07:00:05 | 3 Jul 2023 | | Successful clinical validation of Clarava™ |
| 29/06/23 | 16:57:41 | 29 Jun 2023 | | Result of AGM |
| 06/06/23 | 07:00:08 | 6 Jun 2023 | | Notice of AGM and posting of Annual Report |
| 05/06/23 | 07:01:02 | 5 Jun 2023 | | 2022 Annual Results |
| 05/06/23 | 07:00:06 | 5 Jun 2023 | | Proposed US pricing for Tutivia™ |
| 31/05/23 | 07:00:07 | 31 May 2023 | | Notice of Results |
| 24/05/23 | 07:01:02 | 24 May 2023 | | Update re. EKF distribution of shares in Verici Dx |
| 24/05/23 | 07:00:12 | 24 May 2023 | | Distribution of shares in Verici Dx plc |
| 24/04/23 | 07:00:09 | 24 Apr 2023 | | Final results timing |
| 28/03/23 | 11:05:40 | 28 Mar 2023 | | Second Price Monitoring Extn |
| 28/03/23 | 11:00:31 | 28 Mar 2023 | | Price Monitoring Extension |
| 28/03/23 | 09:05:35 | 28 Mar 2023 | | Second Price Monitoring Extn |
| 28/03/23 | 09:00:21 | 28 Mar 2023 | | Price Monitoring Extension |
| 27/03/23 | 16:35:13 | 27 Mar 2023 | | Price Monitoring Extension |
| 27/03/23 | 11:05:45 | 27 Mar 2023 | | Second Price Monitoring Extn |
| 27/03/23 | 11:00:29 | 27 Mar 2023 | | Price Monitoring Extension |
| 22/03/23 | 07:00:04 | 22 Mar 2023 | | Operational Update |
| 21/03/23 | 16:40:29 | 21 Mar 2023 | | Second Price Monitoring Extn |
| 21/03/23 | 16:35:16 | 21 Mar 2023 | | Price Monitoring Extension |
| 13/03/23 | 07:00:07 | 13 Mar 2023 | | Statement re. Silicon Valley Bank |
| 09/03/23 | 07:00:06 | 9 Mar 2023 | | Two key patents granted in the US |
| 02/03/23 | 07:00:06 | 2 Mar 2023 | | CLIA Certificate of Compliance |
| 27/02/23 | 14:00:10 | 27 Feb 2023 | | Price Monitoring Extension |
| 07/12/22 | 07:00:07 | 7 Dec 2022 | | Director/PDMR Shareholding |
| 01/12/22 | 18:07:55 | 1 Dec 2022 | | Correction: Holding(s) in Company |
| 03/10/22 | 07:00:14 | 3 Oct 2022 | | Product rebranding as Tutivia™ |
| 07/09/22 | 07:00:03 | 7 Sept 2022 | | Half-year Report |
| 06/09/22 | 07:00:12 | 6 Sept 2022 | | Positive results for Clarava from validation study |
| 05/09/22 | 07:00:11 | 5 Sept 2022 | | Notice of Results |
| 02/09/22 | 16:41:17 | 2 Sept 2022 | | Second Price Monitoring Extn |
| 02/09/22 | 16:35:46 | 2 Sept 2022 | | Price Monitoring Extension |
| 27/06/22 | 15:17:18 | 27 Jun 2022 | | Result of AGM and voting results |
| 24/06/22 | 07:00:05 | 24 Jun 2022 | | Holding(s) in Company |
| 20/06/22 | 07:30:03 | 20 Jun 2022 | | Distribution of Verici Dx shares by EKF |
| 16/06/22 | 07:00:09 | 16 Jun 2022 | | Investor Presentation |
| 15/06/22 | 10:57:02 | 15 Jun 2022 | | CEO Video Interview |
| 14/06/22 | 09:00:02 | 14 Jun 2022 | | Further data from Tuteva™ validation study |
| 09/06/22 | 07:00:05 | 9 Jun 2022 | | Commercial Team Appointments |
| 25/05/22 | 12:00:07 | 25 May 2022 | | Posting of Annual Report & Accounts |
| 19/05/22 | 07:00:09 | 19 May 2022 | | Final Results |
| 12/05/22 | 07:00:08 | 12 May 2022 | | Results of Tuteva™ clinical validation study |
| 01/04/22 | 07:00:09 | 1 Apr 2022 | | Clinical Validation Study Update |
| 23/03/22 | 18:12:28 | 23 Mar 2022 | | Holding(s) in Company |
